Skip to main content
ZWS $50.97 +0.47%
ZWS logo

ZWS · Zurn Elkay Water Solutions Corp

Track ZWS — free
$50.97 +0.24 (+0.47%) At close · Aug 14
Market Cap
$8.58B
Shares
166.87M
All earnings calls

Earnings call · FY2026 Q2

Zurn Elkay Water Solutions Corp Q2 FY2026 Earnings Call

Zurn Elkay Water Solutions Corp Q2 FY2026 Earnings Call

Concluded Jul 20, 2026 Audio replay
Jul 20, 2026 9:23 18 turns
Period
FY2026 Q2
Runtime
9:23
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Zurn Elkay delivered Q2 2026 net sales of $491 million (+10% core sales) with adjusted EBITDA margins of 27.7% (+120 bps YoY), and raised full-year 2026 adjusted EBITDA guidance to $503–$513 million.

Drinking Water Filtration 10 MRO/Retrofit Mix 9 80-20 Portfolio Review 8 IntelliHot / Tankless 8 Adjacency Growth Strategy 6 End Market Demand 6

Management tone

Positive

Net tone +25 · moderate hedging

Grounding quotes
  • “we think we're in a great segment of a very big market that will convert over a long period of time”
  • “we're still seeing good unit volume growth. I wouldn't call out any discernible changes in sort of our end market view”
  • “I don't know that I would give it to you per year. I think it's going to be one of those things where, you know, as we look at these $100 to $200 million markets and bring things where we can develop a meaningful share”
  • “I don't know that we have a target other than to say it really creates a hedge against new construction activity”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Net sales rose 10% to $491 million with core sales growth of 10% year over year.
  • Adjusted EBITDA grew to $136 million (27.7% margin), expanding 120 bps versus the year-ago quarter.
  • Net income from continuing operations increased to $113 million ($0.67 diluted EPS) from $50 million ($0.29) a year ago.
  • Full-year 2026 adjusted EBITDA guidance raised to $503–$513 million, implying ~140 bps margin expansion vs. 2025 excluding tariff refunds.
  • Q3 core sales growth guided at ~6%–7% with adjusted EBITDA margins around 28%.
  • Deployed $50 million in share repurchases in Q2 (1.0 million shares), bringing H1 buybacks to $100 million, and net debt leverage of 0.3x.

Risks & pressure points

  • Q4 2026 core sales growth expected only in the mid-single digits, a step-down from Q3 guidance.
  • Compounding benefit of pricing put in place last year is less in the second half versus the first half.
  • Q4 guidance described as a 'place marker' with no specific updated figure yet.

Key moments

Jump directly to management's words in the synchronized transcript.

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$0.11
Full-screen source Call document